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the antimicrobial action of fatty acids,
lipids, and the hostile pH of the skin
surface. Human b-defensin-2 mRNA
can also be induced in SZ95 sebocytes
by P. acnes (Nagy et al., 2006), and
psoriasin adds to the mixture. We show
here that combining only two antimi-
crobials (LL-37 and psoriasin) produced
a synergistic effect against P. acnes and
greatly increased the potency of cathe-
licidin. The actual concentration of
b-defensins, psoriasin, or other poten-
tial antimicrobial peptides in the sebac-
eous gland remains unknown, but the
current findings support the conclusion
that the sebaceous gland contributes
to epithelial defense by the release of
multiple antimicrobial molecules to
the skin surface. LL-37 may contribute
more to inflammation surrounding the
sebaceous gland than in antimicrobial
defense (Yamasaki et al., 2007).
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TO THE EDITOR
Acne remains both a distressing and
sometime serious skin condition with
both environmental and hereditary
factors playing an important role in this
disease. An example of the former is the
association of chloracne with dioxin
exposure, so much so that chloracne is
considered a clinical sign of dioxin
exposure (Pelclova et al., 2006); an
example of the latter is correlative
association between polymorphism in
the cytochrome P450 1A1 (CYP1A1)
gene and acne (Paraskevaidis et al.,
1998). CYP1A1 catabolises the meta-
bolism of xenobiotics, including the
oxygenation of polycyclic aromatic
hydrocarbons, with the most potent
known inducer of CYP1A1 being 2,3,
7,8-tetrachlorodibenzo-p-dioxin (Nohara
et al., 2006).
We have generated transgenic mice
that indicate basal CYP1A1 gene acti-
vity is restricted to the sebaceous gland
in mice. The transgene differs from that
described previously (Campbell et al.,
1996) in that the CYP1A1 gene promo-
ter drives the expression of enhanced
green fluorescent protein (EGFP), a red-
shift variant of wild-type green fluo-
rescent protein. EGFP is excitable using
blue light of wavelength 488 nm and is
detected by monitoring light of wave-
length 509 nm. The transgenic mice
were generated using standard pro-
nuclear microinjection on a mixed
C57/BL6CBA background. Activation
of EGFP can be studied in animals
without the use of sophisticated imageAbbreviations: CYP1A1, cytochrome P450 1A1; EGFP, enhanced green fluorescent protein
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analysis systems. These studies were
approved by the Animal Ethics Com-
mittee of the Roslin Institute.
While utilising these mice in liver
toxicity studies, we observed that adult
transgenic mice were easily identifi-
able by their ‘‘green’’ ears (Figure 1a).
Low-resolution imaging of ear punches
indicated that green fluorescent
protein activity rather than generalised
transgene activity dispersed through-
out the epithelium was largely res-
tricted to define three-dimensional
structures within the skin (Figure 1b).
Immunostaining indicated that basal
CYP1A1-driven EGFP activity in the
skin was predominantly detected in
the sebaceous gland (Figure 1d). Ani-
mals showed expression predomi-
nantly in the sebaceous gland, with
reduced expression elsewhere in the
skin, including the epidermis. Both
epidermal and sebaceous expression
were elevated with 3-methylchlora-
thene, with the majority of activity
occurring in the sebaceous gland
(Figure 1c).
Sebaceous glands are small, saccu-
lated, glandular organs found associated
with hair follicles in the epidermis. They
secrete sebum in a holocrine manner,
contributing to the integrity of the skin
barrier (Zouboulis, 2004). CYP1A1 acti-
vity has been reported in skin and is
induced upon topical drug treatment
(Smith et al., 2006); however, we have
limited understanding of the non-
induced function of CYP1A1 in tissue.
The sebaceous gland contributes to skin
barrier function. Given the association
of CYP1A1 and acne (Paraskevaidis
et al., 1998), it is tempting to speculate
that the observed strong CYP1A1 expres-
sion in the sebaceous gland relates to
inflammation. However, there is evi-
dence that sebum (Katsuta et al., 2005),
and more particularly cytochrome P450,
activity is involved in the permeability
barrier (Behne et al., 2000), whereas
CYP1A1 is also involved in combating
xenobiotics (Zouboulis, 2004). Without
experimental study we are unable to
associate the high CYP1A1 expression in
the sebaceous gland with specific barrier
function.
Sebaceous gland and epidermis both
show 3-methylchlorathene induction of
CYP1A1 activity. The level of activity in
the epidermis was always considerably
lower than that in the sebaceous gland.
This suggests that the sebaceous gland
may have the predominant role in
elimination of toxins and that barrier
lipid production is influenced by xeno-
biotics. We suggest that CYP1A1 has a
role in normal skin barrier function and
that its role in acne, in particular
neonatal acne, which is characterised
by high sebum excretion rate, warrants
further investigation.
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Figure 1. CYP1A1 gene activity in sebaceous gland of mice. (a) Wild-type and (b, c) transgenic CYP1A1–EGFP live mouse and ear punch illuminated with
blue light of wavelength 488 nm and detected by monitoring light of wavelength 509 nm. Examples of basal transgene activity (b) or transgene activity
induced by intraperitoneal injection of 3-methylchlorathene suspension in corn oil by at 40mg g1 body weight are shown. (d) Immunostained ear section
of mouse shown in (b) confirming predominant CYP1A1 (pink) location to the sebaceous gland surrounding the hair shaft (blue). Bar¼ 1mm.
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